Use this dropdown to select your preferred language.
Shiseido China is a comprehensive organizational structure that integrates production, marketing, and research and development. At Shiseido China, we are committed to discovering the differences and changes in the needs of Chinese consumers, investing in research, development and production in China, and introducing a more diverse brand portfolio to respond more quickly and effectively to our customers.
关于赫力昂
赫力昂（伦敦证交所/ 纽约证交所上市代码：HLN）旨在成为消费健康领域的全球领导者，践行“以人为本，提升每日健康”的公司使命。赫力昂的产品组合涵盖五大品类：口腔健康、疼痛管理、呼吸健康、消化健康、营养健康。赫力昂将深受信赖的科技和对人类健康的理解相结合，打造经典的品牌，包括钙尔奇、善存、舒适达、芬必得、扶他林、新康泰克、百多邦、辅舒良、保丽净等。
如需更多信息，请查阅www.haleon.com
The Deloitte brand entered the China market in 1917 with the opening of an office in Shanghai. Today, Deloitte China delivers a comprehensive range of audit & assurance, consulting, financial advisory, risk advisory and tax services to local, multinational and growth enterprise clients in China.
Philip Morris International (PMI) is one of the world’s leading international tobacco companies, with a workforce of over 71,000. PMI is building its future on replacing cigarettes with smoke-free products that—while not risk-free—are a far better choice than cigarette smoking.
Philip Morris (China) Management Co., Ltd was founded in 2003. Our HQ office is in Beijing and we have branch offices in Shanghai, Guangzhou and Chengdu.
At Johnson & Johnson, we believe health is everything. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.
Eisai’s affiliates in China are wholly-owned by Eisai Co., Ltd. (Eisai), a Japanese multinational pharmaceutical company headquartered in Tokyo, with strong R&D capabilities.
Eisai has been smoothly developing its business in China since the early 1990s, starting with the establishment of Shenyang Eisai Pharmaceutical Co., Ltd. in 1991, followed by the establishment of Eisai Suzhou Pharmaceutical Co., Ltd, and was officially renamed Eisai China.